Related Experiment Videos
Stage IB cervical carcinoma: a clinical audit
M N Gaze1, C G Kelly, P R Dunlop
1Department of Clinical Oncology, Western General Hospital, Edinburgh, UK.
The British Journal of Radiology
|November 1, 1992
Summary
For FIGO Stage IB cervical cancer, radical radiotherapy and primary surgery showed similar survival and local control rates. However, irradiated patients experienced significantly higher rates of late bladder and bowel morbidity.
Area of Science:
- Oncology
- Gynecologic Oncology
- Clinical Oncology
Background:
- Cervical cancer management involves surgery and radiotherapy.
- FIGO Stage IB represents locally advanced disease.
- Treatment outcomes and morbidity require continuous evaluation.
Purpose of the Study:
- To compare the efficacy and morbidity of primary surgery versus radical radiotherapy for FIGO Stage IB cervical cancer.
- To identify prognostic factors influencing outcomes in this patient cohort.
Main Methods:
- Retrospective review of 140 FIGO Stage IB cervical cancer patients treated between 1979-1984.
- Analysis of treatment modalities (primary surgery with or without adjuvant radiotherapy vs. radical radiotherapy).
- Evaluation of 5-year survival, cause-specific survival, local tumor control, and treatment-related morbidity.
Main Results:
- Crude 5-year survival was 72%, cause-specific survival was 78%, and local tumor control was 72%.
- No significant difference in survival or local control was observed between surgical and radiotherapy groups.
- Irradiated patients with bulky tumors had worse outcomes; however, late bladder and bowel morbidity was significantly higher in the irradiated group.
Conclusions:
- Primary surgery offers no survival or local control benefit over radical radiotherapy for Stage IB cervical cancer.
- Radical radiotherapy is associated with significantly higher treatment-related late bladder and bowel morbidity.
- No significant independent prognostic variables were identified in multivariate analysis.